Vor Biopharma
Price & Volume
Stats
See more52W Range | $6.50-$50.20 |
Market Cap | $1.1B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$70.40 |
News
See moreYahoo Finance • last month
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
Yahoo Finance • 2 months ago
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
Yahoo Finance • 7 months ago
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
About
CEO | Dr. Jean-Paul Kress M.D. |
CFO | Mr. Sandesh Mahatme L.L.M. |
Address | 500 Boylston Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |